Overview Financials News + Filings IR Vault Key Docs Charts Transactions Ownership Insiders |
SUNOCO INC (SUN)
|
Add to portfolio |
|
|
Price: |
$41.59
| | Metrics |
OS: |
104.7
|
M
| |
-116
|
% ROE
|
Market cap: |
$4.36
|
B
| |
199
|
% ROIC
|
Net debt:
|
$543
|
M
| |
|
|
EV:
|
$4.9
|
B
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
($1.4)
|
B
| |
|
|
EBIT
|
($1.7)
|
B
| |
|
|
EPS |
($16.13)
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
Date Filed | Type | Description |
06/03/2019 |
GN
| Attis Industries Completes Acquisition of Corn Ethanol Plant from Sunoco LP |
02/28/2019 |
GN
| Research Report Identifies Sunoco LP, Citrix, Alkermes plc, CubeSmart, Morningstar, and Synopsys with Renewed Outlook — Fundamental Analysis, Calculating...
|
01/22/2019 |
GN
| Attis Industries Enters into a Definitive Agreement to Acquire Corn Ethanol Facility and Grain Malting Operation from Sunoco LP |
12/06/2018 |
GN
| Analysis: Positioning to Benefit within Paratek Pharmaceuticals, Chesapeake Utilities, Eros International, Sunoco LP, Delek Logistics Partners, and Johns...
|
06/22/2018 |
GN
| New Research Coverage Highlights Perry Ellis International, Standex International, Fastenal, Viad, Boston Private Financial, and Sunoco LP — Consolidated...
|
05/03/2018 |
GN
| Analysis: Positioning to Benefit within PTC, Black Hills, Mack-Cali Realty, Milacron, Rexahn Pharmaceuticals, and Sunoco LP — Research Highlights Growth,...
|
05/03/2018 |
GN
| Analysis: Positioning to Benefit within PTC, Black Hills, Mack-Cali Realty, Milacron, Rexahn Pharmaceuticals, and Sunoco LP — Research Highlights Growth,...
|
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 | Dec-31-04 |
Revenues | 46,916.0 | 36,400.0 | 29,696.0 | 49,485.0 | 42,569.0 | 38,715.0 | 33,754.0 | 25,468.0 |
Revenue growth | 28.9% | 22.6% | -40.0% | 16.2% | 10.0% | 14.7% | 32.5% | 141732884.6% |
Cost of goods sold | 48,155.0 | 34,575.0 | 29,007.0 | 46,826.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross profit | -1,239.0 | 1,825.0 | 689.0 | 2,659.0 | 42,569.0 | 38,715.0 | 33,754.0 | 25,468.0 |
Gross margin | -2.6% | 5.0% | 2.3% | 5.4% | 100.0% | 100.0% | 100.0% | 100.0% |
Selling, general and administrative | 645.0 | 640.0 | 651.0 | 798.0 | 880.0 | 881.0 | 946.0 | 873.0 |
EBIT | -2,685.0 | 302.0 | -862.0 | -111.0 | 41,221.0 | 37,375.0 | 1,593.0 | 965.0 |
EBIT margin | -5.7% | 0.8% | -2.9% | -0.2% | 96.8% | 96.5% | 4.7% | 3.8% |
Pre-tax income | -2,404.0 | 563.0 | -596.0 | 1,400.0 | 1,312.0 | 1,580.0 | 1,580.0 | 995.0 |
Income taxes | -1,501.0 | 118.0 | -358.0 | 442.0 | 450.0 | 601.0 | 606.0 | 390.0 |
Tax rate | 62.4% | 21.0% | 60.1% | 31.6% | 34.3% | 38.0% | 38.4% | 39.2% |
Earnings from continuing ops | -1,361.0 | 740.0 | -408.0 | 1,803.0 | 862.0 | 979.0 | 974.0 | 605.0 |
Earnings from discontinued ops | -323.0 | -61.0 | 79.0 | -69.0 | 99.0 | | | |
Net income | -1,684.0 | 679.0 | -329.0 | 1,734.0 | 961.0 | 979.0 | 974.0 | 605.0 |
Net margin | -3.6% | 1.9% | -1.1% | 3.5% | 2.3% | 2.5% | 2.9% | 2.4% |
|
Diluted EPS | ($11.76) | $6.15 | ($3.49) | $15.40 | $7.18 | $7.59 | $7.08 | $4.04 |
Shares outstanding (diluted) | 115.7 | 120.3 | 116.9 | 117.1 | 120.0 | 129.0 | 137.5 | 149.8 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|